Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Alternative Applications For Drug Delivery: Nasal And Pulmonary Routes
Published 2007 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
For treatment of human diseases, nasal and pulmonary routes of drug delivery are gaining increasing importance. These routes provide promising alternatives to parenteral drug delivery particularly for peptide and protein therapeutics. For this purpose, several drug delivery systems have been formulated and are being investigated for nasal and pulmonary delivery. These include liposomes, proliposomes, microspheres, gels, prodrugs, cyclodextrins and others. In this chapter, nasal and pulmonary drug delivery mechanisms and some of the relevant drug delivery formulations are evaluated
This paper references
Targeted brain delivery of 17β-estradiol via nasally administered water soluble prodrugs
Abeer M. Al-Ghananeem (2008)
Alveolobronchiolar transport mechanisms.
G. Green (1973)
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
R. Fernández-Urrusuno (2004)
Correlation between nasal ciliary beat frequency and mucus transport rate in volunteers
G. Duchateau (1985)
Tolerability and Absorption Enhancement of Intranasally Administered Octreotide by Sodium Taurodihydrofusidate in Healthy Subjects
T. Kissel (2004)
Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems.
M. Ikechukwu Ugwoke (2000)
Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits.
Y. Watanabe (1992)
Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system.
V. Leitner (2004)
Effects of exercise and eucapnic hyperventilation on bronchial clearance in man.
R. Wolff (1977)
Technology evaluation: cystic fibrosis therapy, Genzyme.
Cockett Mi (1999)
Prolonged delivery of nicotine in rats via nasal administration of proliposomes.
B. Jung (2000)
Clearance characteristics of chitosan based formulations in the sheep nasal cavity.
R. Soane (2001)
Anatomy, physiology and function of the nasal cavities in health and disease.
Intranasal administration of human growth hormone (hGH) in combination with a membrane permeation enhancer in patients with GH deficiency: a pharmacokinetic study.
L. Hedin (1993)
Nasal mucociliary clearance as a factor in nasal drug delivery.
Permeability of insulin entrapped in liposome through the nasal mucosa of rabbits.
Y. Maitani (1992)
The Nasal Mucociliary Clearance: Relevance to Nasal Drug Delivery
N. G. Schipper (2004)
Optimization of systemic nasal drug delivery with pharmaceutical excipients.
Nasal systemic drug delivery
Y. Chien (1989)
Intranasal drug delivery for systemic medications.
Y. Chien (1987)
Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers.
F. Verra (1995)
Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel
K. Morimoto (1985)
Modified-Release Drug Delivery Technology
M. Rathbone (2002)
Drug Metabolism in the Nasal Mucosa
Mohamadi A. Sarkar (2004)
Intranasal Administration of Insulin With Phospholipid as Absorption Enhancer: Pharmacokinetics in Normal Subjects
K. Drejer (1992)
Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs.
E. Marttin (1998)
Confocal Laser Scanning Microscopic Visualization of the Transport of Dextrans After Nasal Administration to Rats: Effects of Absorption Enhancers
E. Marttin (2004)
Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
Prapasri Sinswat (2003)
Epithelial Transport and Bioavailability of Intranasally Administered Human Growth Hormone Formulated with the Absorption Enhancers Didecanoy‐L‐α‐phosphatidylcholine and α‐Cyclodextrin in Rabbits
C. Agerholm (1994)
Twenty-four hour ambulatory nasal pH monitoring.
S. S. Hehar (1999)
Degradable starch microspheres as a nasal delivery system for insulin
E. Björk (1988)
Controlled drug delivery systems
J. Kost (1989)
The use of inhaled liposome formulations for drug delivery to the lungs and systemic circulation.
Fielding Rm (1989)
Chitosan salts as nasal sustained delivery systems for peptidic drugs
T. Cerchiara (2003)
Nasal administration of insulin using bioadhesive microspheres as a delivery system
N. Farraj (1990)
Preparation and in vitro characterization of gelatin microspheres containing Levodopa for nasal administration.
B. Brime (2000)
Prostaglandin E2 activates the ciliary beat frequency of cultured human nasal mucosa via the second messenger cyclic adenosine monophosphate
B. Haxel (2001)
The Bioavailability of Intranasal Salmon Calcitonin in Healthy Volunteers with and Without a Permeation Enhancer
W. Lee (2004)
Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis
S C Hyde (2000)
ENHANCEMENT OF NASAL ABSORPTION OF CALCITONIN LOADED IN LIPOSOMES
S. Law (2001)
Intranasal Drug Delivery
D. Wermeling (2002)
Enhanced nasal absorption of insulin in rats using lysophosphatidylcholine
L. Illum (1989)
Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts.
P. Tengamnuay (2000)
Absorption Enhancing Effect of Cyclodextrins on Intranasally Administered Insulin in Rats
F. H. H. M. Merkus (2004)
Use of Chemical Enhancers for Nasal Drug Delivery
R. Ponti (1991)
Nasal route and drug delivery systems
S. Türker (2004)
Oxprenolol-loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization.
M. Preda (2003)
Pulmonary Delivery of Drugs by Inhalation
I. Gonda (2002)
Effect of oral bronchodilators on lung mucociliary clearance during sleep in patients with asthma.
A. Hasani (1993)
Intranasal drug delivery.
Long‐Term Use of Preservatives on Rat Nasal Respiratory Mucosa: Effects of Benzalkonium Chloride and Potassium Sorbate
J. Cho (2000)
Effects of Absorption Enhancers on Human Nasal Tissue Ciliary Movement in Vitro
W. Hermens (2004)
The effect of molecular size on the nasal absorption of water‐soluble compounds in the albino rat
A. Fisher (1987)
Effectiveness of liposomes as adjuvants of orally and nasally administered tetanus toxoid
H. O. Alpar (1992)
The biopharmaceutical aspects of nasal mucoadhesive drug delivery
M. I. Ugwoke (2001)
The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium
C. Kitson (1999)
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
A. Vila (2004)
Scintigraphic evaluation in rabbits of nasal drug delivery systems based on carbopol 971p((R)) and carboxymethylcellulose.
M. I. Ugwoke (2000)
Effect of polymers and microspheres on the nasal absorption of insulin in rats
L. Rydén (1992)
Promotion of nasal absorption of insulin by glycyrrhetinic acid derivatives. I.
M. Mishima (1989)
Cyclodextrins as Nasal Absorption Promoters of Insulin: Mechanistic Evaluations
Z. Shao (2004)
Nasal absorption of nifedipine from gel preparations in rats.
K. Morimoto (1987)
Pharmaceutical applications of mucoadhesion for the non‐oral routes
K. Edsman (2005)
Intranasal vaccination against plague, tetanus and diphtheria.
H. O. Alpar (2001)
Bioadhesive microspheres as a potential nasal drug delivery system
L. Illum (1987)
This paper is referenced by
The potential of electronic cigarette technology to deliver small molecular weight drugs to the central nervous system
Montserrat Castillo Carrizales (2019)
Liposomal Incorporation to Improve Dissolution and Stability of Rosmarinic Acid and Carvacrol Extracted from Oregano (O. onites L.)
J. Baranauskaite (2018)
Pulmonary Drug Delivery: A Promising Approach
N. Shah (2012)
UNIVERSITY OF LJUBLJANA FACULTY OF PHARMACY TINA OBERSKI HYDROXYPROPYL-β- CYCLODEXTRIN/CICLESONIDE COMPLEXES FOR INHALATION POWDERS
KOMPLEKSI CIKLESONIDA (2012)
A REVIEW ON PULMONARY DRUG DELIVERY SYSTEM
Shubham Upadhye (2015)
Nasal route: an alternative approach for antiemetic drug delivery
Y. Ozsoy (2011)
Nano- and microcrystals of griseofulvin subcutaneously administered to rats resulted in improved bioavailability and sustained release
K. Sigfridsson (2019)
In vivo challenges of anti-diabetic peptide therapeutics: Gastrointestinal stability, toxicity and allergenicity
Pei Gee Yap (2020)
Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB
Kaksha Sankhe (2019)